UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Accenture
ACN
|
+$412M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
| 4 |
ConocoPhillips
COP
|
+$262M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$237M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.78B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$326M |
| 3 |
Microsoft
MSFT
|
+$258M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$206M |
| 5 |
UnitedHealth
UNH
|
+$198M |
Sector Composition
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CCC Intelligent Solutions
CCCS
$6.25B
| $866K | ﹤0.01% |
95,142
+1,335
| +1% | +$12.1K |
|
2002
Kimball Electronics
KE
$735M
| $865K | ﹤0.01% |
50,451
+3,607
| +8% | +$61.9K |
|
2003
National Healthcare
NHC
$1.76B
| $865K | ﹤0.01% |
13,660
-708
| -5% | -$44.8K |
|
2004
Resources Connection
RGP
$167M
| $865K | ﹤0.01% |
47,876
+6,611
| +16% | +$119K |
|
2005
Open Lending Corp
LPRO
$253M
| $864K | ﹤0.01% |
107,518
+5,310
| +5% | +$42.7K |
|
2006
CareDx
CDNA
$710M
| $863K | ﹤0.01% |
50,686
-1,593
| -3% | -$27.1K |
|
2007
SSR Mining
SSRM
$4.46B
| $862K | ﹤0.01% |
58,593
| – | – |
|
2008
Orion
OEC
$570M
| $862K | ﹤0.01% |
64,534
-605
| -0.9% | -$8.08K |
|
2009
Kearny Financial
KRNY
$415M
| $861K | ﹤0.01% |
81,061
-3,698
| -4% | -$39.3K |
|
2010
Veeco
VECO
$1.52B
| $855K | ﹤0.01% |
46,685
-2,636
| -5% | -$48.3K |
|
2011
Washington Trust Bancorp
WASH
$570M
| $852K | ﹤0.01% |
18,324
-1,018
| -5% | -$47.3K |
|
2012
Celldex Therapeutics
CLDX
$1.66B
| $850K | ﹤0.01% |
30,242
+803
| +3% | +$22.6K |
|
2013
Central Pacific Financial
CPF
$834M
| $849K | ﹤0.01% |
41,026
+7,669
| +23% | +$159K |
|
2014
Enbridge
ENB
$106B
| $848K | ﹤0.01% |
22,859
-1,613
| -7% | -$59.8K |
|
2015
MarineMax
HZO
$545M
| $846K | ﹤0.01% |
28,400
+3,354
| +13% | +$99.9K |
|
2016
Tidewater
TDW
$2.97B
| $846K | ﹤0.01% |
38,967
+3,659
| +10% | +$79.4K |
|
2017
Veru
VERU
$56.6M
| $845K | ﹤0.01% |
7,337
+1,265
| +21% | +$146K |
|
2018
IMAX
IMAX
$1.67B
| $842K | ﹤0.01% |
59,613
+3,349
| +6% | +$47.3K |
|
2019
Relmada Therapeutics
RLMD
$53.4M
| $839K | ﹤0.01% |
22,671
+9,142
| +68% | +$338K |
|
2020
TG Therapeutics
TGTX
$5.05B
| $838K | ﹤0.01% |
141,579
-5,474
| -4% | -$32.4K |
|
2021
Akero Therapeutics
AKRO
$3.46B
| $838K | ﹤0.01% |
24,609
-9,263
| -27% | -$315K |
|
2022
RadNet
RDNT
$5.49B
| $838K | ﹤0.01% |
41,165
-4,817
| -10% | -$98K |
|
2023
PureCycle Technologies
PCT
$2.38B
| $837K | ﹤0.01% |
103,757
+32,645
| +46% | +$263K |
|
2024
Helix Energy Solutions
HLX
$923M
| $837K | ﹤0.01% |
216,847
-15,507
| -7% | -$59.9K |
|
|
HIBB
2025
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $833K | ﹤0.01% |
16,726
-3,873
| -19% | -$193K |
|